glp 1 receptor agonists weight loss Top GLP-1 Balance Efficacy, Safety GLP-1 Receptor Agonists at the

Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al

Mo1908: glucagon-like peptide-1 receptor agonist use in patients with perianal fistulizing Crohns disease is well tolerated and leads to weight loss and clinical improvement in fistula activity

Front Pharmacol 2020;11:432.

Induced human regulatory T cells express the glucagon-like peptide-1 receptor

Greater efficacy

Assessing GLP-1 RA Exposure and Pregnancy Outcomes To evaluate these concerns, the researchers conducted a study assessing gestational weight gain and related secondary outcomes among individuals exposed to GLP-1 RAs in the prepregnancy and early pregnancy period compared with unexposed individuals with similar baseline characteristics